MeiraGTx Holdings plc (MGTX) Debt Components
- 2026-03-31: Notes Payable, CurrentUSD $24.87M; Debt Instrument, Unamortized DiscountUSD (m).
- 2025-12-31: Notes Payable, CurrentUSD $24.65M; Debt Instrument, Unamortized DiscountUSD (m).
- 2025-09-30: Notes Payable, CurrentUSD $74.06M; Debt Instrument, Unamortized DiscountUSD (m).
- 2024-12-31: Notes Payable, CurrentUSD (m); Debt Instrument, Unamortized DiscountUSD $1.80M.
MeiraGTx Holdings plc Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Notes Payable, Current USD | Debt Instrument, Unamortized Discount USD |
|---|---|---|
| 2026-03-31 | $24.87M | (m) |
| 2025-12-31 | $24.65M | (m) |
| 2025-09-30 | $74.06M | (m) |
| 2024-12-31 | (m) | $1.80M |
| 2017-12-31 | $1.44M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |